Mumbai : Telangana based Sai Parenteral Limited is a diversified pharmaceutical formulations company with capabilities in research, development and manufacturing has fixed the price band of Rs 372/- to Rs 392/- per Equity Share of face value Rs 5/- each for its maiden initial public offer.

The Initial Public Offering of the Company will open on Tuesday, March 24, 2026, for subscription and close on Friday, March 27, 2026.

Investors can bid for a minimum of 38 Equity Shares and in multiples of 38 Equity Shares thereafter.

Equity shares outstanding as on date 3,69,08,823 Equity Shares of Rs 5 each.

The IPO is a fresh issue up to Rs 285 crore and an offer-for-sale for up to 3,157, 880 shares by investors – Vikasa India EIF I Fund, Tilokchand Punamchand Ostwal, Devendra Chawla, Bhanwar Lal Chandak, Ashish Maheshwari, Sreelekha Ganta, Padma Guntupalli, Vijay Gondi, Bhautik Mukund Shah and Nilesh Pravinchandra Doshi.

Arihant Capital Market is the book-running lead managers, and Bigshare Services Private Limited is the registrar of the offer.

The Offer is being made through the book-building process, wherein not more than 50% of the net offer is allocated to qualified institutional buyers, and not less than 15% and 35% of the net offer is assigned to non-institutional bidders and retail individual bidders respectively.